Microarray-based comparative analysis of HAT activity in the hormone-sensitive (HS) prostate cancer cell line (LNCaP) and its castrate-resistant (CR) daughter cell line (C4−2) has revealed increased HAT activity against specific histone sites of H3 in the CR cell line compared to its HS equivalent [106]. This evidence concerns the gene TMPRSS11D and prostate cancer.